Stomach Cancer Clinical Trials

08/04/2025

Recruiting
Avutometinib and Defactinib in Diffuse Gastric Cancer

https://clinicaltrials.gov/study/NCT06487221

08/04/2025

Recruiting
Comparison of Outcomes of Multiple Platforms for Assisted Robotic Gastrectomy
https://clinicaltrials.gov/study/NCT06362070

01/28/2025

Global Genes recently released Early and Often: Reimagining patient community engagement to improve clinical trials feasibility.

The paper, authored by the Global Genes Corporate Alliance with input from the Global Genes’ Global Advocacy Alliance, argues drug developers can improve the time and cost of rare disease clinical trials through better engagement with the patient community to better inform discovery and development of therapies. This report shows that listening to patient communities isn’t just helpful—it’s transformational. Advocacy leaders and patients provide the qualitative insights that traditional data can’t capture, uncovering critical factors that drive clinical trial success. Your Role Is Essential.

Download Your Copy Today.

01/13/2025

Patient Webinar: Why Should I Consider a Clinical Trial?

Free NCCN patient webinar for those wanting to learn more about Clinical Trials.

10/23/2024

There is still time to register to attend in person or virtually for our Fall 2024 Spotlight on Stomach Cancer at the Penn Medicine - Abramson Cancer Center

Register today!

https://www.med.upenn.edu/stomach2024/

In Person or Virtually      Law Auditorium | Jordan Medical Education CenterPerelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104

10/18/2024

You have been invited to participate in a new Interview Opportunity for Gastric Cancer Patients and Caregivers. If you qualify, you may be scheduled for a 60-minute online interview.

If you qualify to complete the interview, you will receive $120.

Please click here to start the survey today.

https://roi-rocket.org/?a=65895&c=73341&s1=nostomachforcancer

Survey Number: 64544

Thanks in advance for your participation. If you have any questions, please email the address below with the survey number.

rachel.cohen@roirocket.com

Please Note: This survey is for research purposes only. There will be no direct sales or promotions due to your participation. Your individual responses will be kept confidential, anonymous, and reported in aggregate.